[hsCRP protein in children and adolescents with diabetes type 1]

Barbara Głowińska-Olszewska1, Mirosława Urban, Jadwiga Peczyńska

  • 1II Klinika Chorób Dzieci AM w Białymstoku. bglowinska@poczta.onet.pl

Insights

High-sensitivity C-reactive protein (hsCRP) levels are elevated in children with type 1 diabetes, particularly those with hypertension and obesity. These findings suggest a low-grade inflammatory state linked to metabolic syndrome in pediatric diabetes.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Risk Factors
  • Inflammatory Markers

Context:

  • Type 1 diabetes in children is associated with an early atherosclerotic process.
  • Limited data exists on inflammatory markers in pediatric type 1 diabetes compared to adults.
  • HsCRP is a novel marker for low-grade inflammation and early atherosclerosis.

Purpose:

  • To assess high-sensitivity C-reactive protein (hsCRP) levels in children and adolescents with type 1 diabetes.
  • To investigate the relationship between hsCRP levels and coexisting risk factors for atherosclerosis.
  • To examine the association with microvascular complications in pediatric type 1 diabetes.

Summary:

  • HsCRP levels were nearly significantly higher in the overall type 1 diabetes group compared to controls.
  • Significantly elevated hsCRP was observed in diabetic children with hypertension and/or obesity.
  • HsCRP correlated with systolic blood pressure, HbA1c, and triglyceride levels.

Impact:

  • Elevated hsCRP in type 1 diabetes with hypertension/obesity indicates a low-grade inflammatory state.
  • This highlights the presence of metabolic syndrome components in pediatric diabetes.
  • Findings emphasize the need for monitoring inflammatory markers in at-risk pediatric populations.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...